Currency in USD
Earnings estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 0.06 | 0.06 | 0.07 | 0.39 |
Low estimate | 0 | 0.02 | 0 | 0.23 |
High estimate | 0.11 | 0.1 | 0.19 | 0.51 |
Year ago EPS | -0.07 | 0.34 | 0.06 | 0.07 |
Revenue estimate | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 6 | 6 | 6 | 6 |
Avg. Estimate | 30.82M | 29.82M | 122.54M | 132.02M |
Low estimate | 29.7M | 27.6M | 120.42M | 125.2M |
High estimate | 32M | 31.45M | 125M | 151.22M |
Year ago sales | N/A | 28.63M | 108.1M | 122.54M |
Sales growth (year/est) | N/A | 4.10% | 13.40% | 7.70% |
Earnings history | 30/12/2022 | 30/03/2023 | 29/06/2023 | 29/09/2023 |
---|
Est. EPS | -0.08 | -0.05 | -0.01 | 0.02 |
Actual EPS | -0.07 | 0.34 | 0.03 | -0.05 |
Difference | 0.01 | 0.39 | 0.04 | -0.07 |
Surprise % | 12.50% | 780.00% | 400.00% | -350.00% |
EPS trend | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | 0.06 | 0.06 | 0.07 | 0.39 |
7 days ago | 0.06 | 0.06 | 0.07 | 0.39 |
30 days ago | 0.04 | 0.05 | 0.13 | 0.34 |
60 days ago | 0.04 | 0.05 | 0.14 | 0.34 |
90 days ago | 0.04 | 0.05 | 0.14 | 0.34 |
EPS revisions | Current qtr. (Dec 2023) | Next qtr. (Mar 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | 2 | N/A | N/A | 2 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | MEDXF | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | 185.70% | N/A | N/A | N/A |
Next qtr. | -82.40% | N/A | N/A | N/A |
Current year | 16.70% | N/A | N/A | N/A |
Next year | 457.10% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |